Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery PartnersSGRY +4.79%63 EV-to-FCF is 37.57 as of Jul. 16, 2026, which is 22% below its 10-year median of 48.25. GuruFocus rates SGRY with a GF Score™ of 63/100 and a GF Value™ of $26.78 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Surgery Partners ranks worse than 78.82% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Surgery Partners's Enterprise Value is $7,815 Mil.
Surgery Partners's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $208 Mil. Therefore, Surgery Partners's EV-to-FCF for today is 37.57.
The historical rank and industry rank for Surgery Partners's EV-to-FCF or its related term are showing as below:
SGRY'
s EV-to-FCF Range Over the Past 10 Years
Min: 20.12 Med: 48.25 Max: 468.89
Current: 37.57
During the past 13 years, the highest EV-to-FCF of Surgery Partners was 468.89. The lowest was 20.12. And the median was 48.25.
SGRY's EV-to-FCF is ranked worse than 78.82% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 18.015
vs SGRY: 37.57
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Surgery Partners's PE Ratio (TTM) for today is calculated as:
Surgery Partners's share price for today is $16.64.
Surgery Partners's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.600.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Surgery Partners EV-to-FCF Related Terms
Surgery Partners EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Surgery Partners's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Surgery Partners's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Surgery Partners's EV-to-FCF falls into.
Surgery Partners's current Enterprise Value is $7,815 Mil.
Surgery Partners's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $208 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners (SGRY) has a EV-to-FCF of 37.57 as of Jul. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Surgery Partners and its competitors. This is 22% below median its historical median of 48.25. Over the past decade, Surgery Partners' EV-to-FCF has ranged from 20.12 to 468.89. According to the industry distribution chart, Surgery Partners ranks #320 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 78.8%.
Is Surgery Partners' EV-to-FCF too high?
Surgery Partners' current EV-to-FCF of 37.57 is 22% below median its 10-year median of 48.25. Over the past 10 years, this metric has ranged from a low of 20.12 to a high of 468.89. The Healthcare Providers & Services industry median EV-to-FCF is 18.02. Surgery Partners' value of 37.57 is 108.5% above this industry median. Based on the distribution chart, Surgery Partners ranks #320 out of 406 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Surgery Partners has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' EV-to-FCF compare to SEM and MD?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #320 out of 406 companies for EV-to-FCF. This places Surgery Partners in the lower half of its industry. The industry median EV-to-FCF is 18.02. Surgery Partners' value of 37.57 is 108.5% above this benchmark. Historically, Surgery Partners' own EV-to-FCF has ranged from 20.12 to 468.89 over the past decade. While the company's 10-year median is 48.25 vs. the industry median of 18.02, Surgery Partners has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.02, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgery Partners's current EV-to-FCF of 37.57 is 108.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Surgery Partners and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current EV-to-FCF is 37.57, which is 22% below median its own 10-year median of 48.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (SGRY) is currently considered Possible Value Trap. The stock's GF Value™ is $26.78, compared to a current price of $16.64 — trading 37.9% below its estimated fair value. The current EV-to-FCF is 37.57, which is 22% below median its 10-year median of 48.25 and 108.5% above the Healthcare Providers & Services industry median of 18.02. Surgery Partners' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Surgery Partners (SGRY), the current EV-to-FCF is 37.57 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (SGRY) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of $16.64 is trading 37.9% below its estimated GF Value™ of $26.78.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for SGRY:
EV-to-FCF: 37.57 (22% below median its 10-year median of 48.25)
GF Value™: $26.78 vs. price of $16.64 (37.9% below fair value)
Industry Position: 108.5% above the Healthcare Providers & Services median (#320 of 406)
No single metric tells the full story. See the SGRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
63GF Score
Get the complete analysis for SGRY
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGRY has been successfully added to your 
